Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5

Assignor

THERAVANCE, INC.

Executed: 2014-06-01

Assignee

THERAVANCE BIOPHARMA R&D IP, LLC

901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080

Covered Properties (4)

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 7,560,469 →

Application: 11/077,436 →

Publication: US 2005/0203134

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 7,816,532 →

Application: 12/328,033 →

Publication: US 2009/0088453

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

Patent: 8,211,915 →

Application: 12/880,752 →

Publication: US 2010/0331375

Biphenyl compounds useful as muscarinic receptor antagonists

Application: 60/552,264 →

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.